Literature DB >> 23821267

A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures.

Dawei Cai1, Hui Nie, Ran Yan, Ju-Tao Guo, Timothy M Block, Haitao Guo.   

Abstract

Chronic hepatitis B remains a substantial public health burden affecting approximately 350 million people worldwide, causing cirrhosis and liver cancer, and about 1 million people die each year from hepatitis B and its complications. Hepatitis B is caused by hepatitis B virus (HBV) infection. As an essential component of the viral life cycle, HBV covalently closed circular DNA (cccDNA) is synthesized and maintained at low copy numbers in the nucleus of infected hepatocytes, and serves as the transcription template for all viral RNAs. Therefore, cccDNA is responsible for the establishment of viral infection and persistence. The presence and longevity of cccDNA may also explain the limitations of current antiviral therapy for hepatitis B. Thus, understanding the mechanisms underlying cccDNA formation and regulation is critical in understanding the HBV pathogenesis and finding a cure for hepatitis B. Here we describe a protocol for HBV cccDNA extraction and detection in detail. The procedure includes two major steps: (1) HBV cccDNA extraction by Hirt protein-free DNA extraction method and (2) HBV cccDNA detection by Southern blot analysis. The method is straightforward and reliable for cccDNA assay with cell culture samples, and it is useful for both HBV molecular biology and antiviral research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23821267      PMCID: PMC5060941          DOI: 10.1007/978-1-62703-484-5_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  26 in total

1.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

3.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays.

Authors:  Tianlun Zhou; Haitao Guo; Ju-Tao Guo; Andrea Cuconati; Anand Mehta; Timothy M Block
Journal:  Antiviral Res       Date:  2006-06-02       Impact factor: 5.970

6.  The hepatitis B virus HBx protein modulates cell cycle regulatory proteins in cultured primary human hepatocytes.

Authors:  Tricia L Gearhart; Michael J Bouchard
Journal:  Virus Res       Date:  2010-10-08       Impact factor: 3.303

7.  Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis.

Authors:  Hsiu-Chen Huang; Chun-Chi Chen; Wen-Cheng Chang; Mi-Hua Tao; Cheng Huang
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

8.  Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus.

Authors:  A Dejean; C Lugassy; S Zafrani; P Tiollais; C Brechot
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

9.  Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.

Authors:  Séverine Margeridon; Sandra Carrouée-Durantel; Isabelle Chemin; Luc Barraud; Fabien Zoulim; Christian Trépo; Alan Kay
Journal:  Antimicrob Agents Chemother       Date:  2008-07-07       Impact factor: 5.191

10.  Nucleotide sequences in human chromosomal DNA from nonhepatic tissues homologous to the hepatitis B virus genome.

Authors:  A K Naumova; M O Favorov; E S Keteladze; V V Nosikov; L L Kisselev
Journal:  Gene       Date:  1985       Impact factor: 3.688

View more
  56 in total

1.  In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Authors:  Xiaonan Zhang; Wei Lu; Ye Zheng; Weixia Wang; Lu Bai; Liang Chen; Yanling Feng; Zhanqing Zhang; Zhenghong Yuan
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

2.  Parvulin 14 and Parvulin 17 Bind to HBx and cccDNA and Upregulate Hepatitis B Virus Replication from cccDNA to Virion in an HBx-Dependent Manner.

Authors:  Umar Saeed; Jumi Kim; Zahra Zahid Piracha; Hyeonjoong Kwon; Jaesung Jung; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.

Authors:  Zahra Zahid Piracha; Umar Saeed; Jumi Kim; Hyeonjoong Kwon; Yong-Joon Chwae; Hyun Woong Lee; Jin Hong Lim; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

4.  T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.

Authors:  Bingqian Qu; Yi Ni; Florian A Lempp; Florian W R Vondran; Stephan Urban
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

5.  Detection of hepatitis B virus infection: A systematic review.

Authors:  Mallika Ghosh; Srijita Nandi; Shrinwanti Dutta; Malay Kumar Saha
Journal:  World J Hepatol       Date:  2015-10-18

6.  Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.

Authors:  Philipp Tropberger; Alexandre Mercier; Margaret Robinson; Weidong Zhong; Don E Ganem; Meghan Holdorf
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-05       Impact factor: 11.205

Review 7.  Novel therapeutic approaches for hepatitis B virus covalently closed circular DNA.

Authors:  Motoko Ohno; Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Akemi Takata; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

8.  DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level.

Authors:  Chunkyu Ko; Sooyoung Lee; Marc P Windisch; Wang-Shick Ryu
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

9.  Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.

Authors:  Shivali S Joshi; Shan Gao; Eliana Castillo; Carla S Coffin
Journal:  Dig Dis Sci       Date:  2019-08-02       Impact factor: 3.199

10.  Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators.

Authors:  Dawei Cai; Xiaohe Wang; Ran Yan; Richeng Mao; Yuanjie Liu; Changhua Ji; Andrea Cuconati; Haitao Guo
Journal:  Antiviral Res       Date:  2016-05-13       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.